U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Rocuronium Bromide Injection
Status: Currently in Shortage
»Date first posted: 02/15/2023
»Therapeutic Categories: Anesthesia

Expand all

Baxter Healthcare (Reverified 11/10/2025)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10) Available
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10) Available

Eugia US LLC (Revised 10/17/2025)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10) Available Check wholesalers for inventory
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05) Available Check wholesalers for inventory

Fresenius Kabi USA, LLC (Reverified 11/05/2025)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) Available Check wholesalers for inventory
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) Available Check wholesalers for inventory. Delay in shipping of the drug
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) Unavailable Backordered. Next release not available at this time. Check wholesaler for inventory. Delay in shipping of the drug

Hikma Pharmaceuticals USA, Inc. (Revised 10/24/2025)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10) Available Additional lots will be available. Product will be made available as it is released.
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10) Available Additional lots will be available. Product will be made available as it is released.

Hospira, Inc., a Pfizer Company (Reverified 10/23/2025)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10) Available
Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10) Available
Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10) Available
Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10) Limited Availability Limited Supply Available. Next Delivery: November 2025; Estimated Recovery: December 2025 Demand increase for the drug

Meitheal Pharmaceuticals, Inc. (Reverified 08/19/2025)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) Available
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11) Available

Mylan Institutional, a Viatris Company (Reverified 11/06/2025)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10) Available
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05) Available

Piramal Critical Care Inc. (Reverified 11/04/2025)

Company Contact Information:
800-414-1901

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41) Limited Availability On allocation Demand increase for the drug
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41) Available

Sagent Pharmaceuticals (Reverified 11/13/2025)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05) Available

Sandoz Inc. (Revised 11/07/2025)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95) Limited Availability Expected recovery: January 2026 Delay in shipping of the drug
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92) Available

XGen Pharmaceuticals DJB, Inc. (Reverified 10/23/2025)

Company Contact Information:
866-390-4411

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) Available Tamarang is the application holder and X-Gen is the distributor/labeler
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) Unavailable Next lots scheduled for release March 2026. Demand increase for the drug
Back to Top